Monday, May 22, 2017

UPDATE 3-Heart problems hit hopes for experimental Amgen, UCB bone drug

* UCB shares drop 13 pct, Amgen also expected to be weak (Adds UCB share price fall, further analyst reaction)

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)